Pharmabiz4h
Symbiosis Pharmaceutical expands business development team in US
Symbiosis Pharmaceutical expands business development team in US: Stirling, UK Saturday, November 30, 2024, 18:00 Hrs [IST] Symbiosis Pharmaceutical Services, a world-class contra ...
Pharmabiz4h
Kane Biotech announces change in US distribution partner for revyve antimicrobial wound gel
Kane Biotech Inc. announces that BioStem Technologies Inc. (BioStem), has recently signed a Letter of Intent to acquire commercial stage products and development technologies from the company’s ...
Pharmabiz5h
Praxis Precision Medicines to showcase updates from pipeline of epilepsy programmes at American Epilepsy Society Annual Meeting 2024
Praxis Precision Medicines, Inc, a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by ...
Pharmabiz6h
Hutchmed announces continued inclusion of Orpathys in the National Reimbursement Drug List in China at current terms
Hutchmed announces continued inclusion of Orpathys in the National Reimbursement Drug List in China at current terms: Hong Kong, Shanghai Saturday, November 30, 2024, 16:00 Hrs [I ...
Pharmabiz8h
NIHR launches £25 million funding to decarbonise the health and social care system
NIHR launches £25 million funding to decarbonise the health and social care system: United Kingdom Saturday, November 30, 2024, 14:00 Hrs [IST] The NIHR has launched a new £25 m ...
Pharmabiz9h
Zai Lab announces the inclusion of Augtyro for ROS1+ NSCLC and other updates in China’s National Reimbursement Drug List
Zai Lab announces the inclusion of Augtyro for ROS1+ NSCLC and other updates in China’s National Reimbursement Drug List: Shanghai Saturday, November 30, 2024, 13:00 Hrs [IST] Z ...
Pharmabiz9h
Entod Pharmaceuticals outperforms market growth in ENT sector
Entod Pharmaceuticals outperforms market growth in ENT sector: Our Bureau, Mumbai Saturday, November 30, 2024, 12:45 Hrs [IST] Entod Pharmaceuticals, a leader in the eye care sect ...
Pharmabiz10h
Quadria Capital Report reveals USD 3 billion annual investment opportunity in climate-health adaptation for India
Quadria Capital Report reveals USD 3 billion annual investment opportunity in climate-health adaptation for India: Our Bureau, Mumbai Saturday, November 30, 2024, 12:20 Hrs [IST] ...
Pharmabiz11h
Bayer further expands global incubator network with Bayer Co.Lab Berlin
Bayer further expands global incubator network with Bayer Co.Lab Berlin: Berlin Saturday, November 30, 2024, 11:00 Hrs [IST] Bayer announced the inauguration of its new life scien ...
Pharmabiz12h
Qiagen introduces novel tools for customizing digital PCR assays and NGS panels for microbial analysis
Venlo, the Netherlands Saturday, November 30, 2024, 10:00 Hrs [IST] ...
Pharmabiz13h
Boehringer Ingelheim introduces Eurican L4 vaccine to protect dogs against leptospirosis
Boehringer Ingelheim introduces Eurican L4 vaccine to protect dogs against leptospirosis: Ingelheim, Germany Saturday, ...
Pharmabiz14h
India takes centre-stage in clinical trials for HIV/AIDS drug
India takes centre-stage in clinical trials for HIV/AIDS drug: Nandita Vijayasimha, Bengaluru Saturday, November 30, 2024, 08:00 Hrs [IST] India has taken centre-stage in clinical ...